The Electrophysiologic Effects of KCNQ1 Extend Beyond Expression of IKs: Evidence from Genetic and Pharmacologic Block

Overview

Journal Cardiovasc Res

Specialty Cardiology & Vascular Diseases

Date 2024 Mar 5

PMID 38442735

Authors

Yuko Wada

Lili Wang

Lynn D Hall

Tao Yang

Laura L Short

Joseph F Solus

Andrew M Glazer

Dan M Roden

Affiliations

Soon will be listed here.

Abstract

Aims: While variants in KCNQ1 are the commonest cause of the congenital long QT syndrome, we and others find only a small IKs in cardiomyocytes from human-induced pluripotent stem cells (iPSC-CMs) or human ventricular myocytes.

Methods And Results: We studied population control iPSC-CMs and iPSC-CMs from a patient with Jervell and Lange-Nielsen (JLN) syndrome due to compound heterozygous loss-of-function (LOF) KCNQ1 variants. We compared the effects of pharmacologic IKs block to those of genetic KCNQ1 ablation, using JLN cells, cells homozygous for the KCNQ1 LOF allele G643S, or siRNAs reducing KCNQ1 expression. We also studied the effects of two blockers of IKr, the other major cardiac repolarizing current, in the setting of pharmacologic or genetic ablation of KCNQ1: moxifloxacin, associated with a very low risk of drug-induced long QT, and dofetilide, a high-risk drug. In control cells, a small IKs was readily recorded but the pharmacologic IKs block produced no change in action potential duration at 90% repolarization (APD90). In contrast, in cells with genetic ablation of KCNQ1 (JLN), baseline APD90 was markedly prolonged compared with control cells (469 ± 20 vs. 310 ± 16 ms). JLN cells displayed increased sensitivity to acute IKr block: the concentration (μM) of moxifloxacin required to prolong APD90 100 msec was 237.4 [median, interquartile range (IQR) 100.6-391.6, n = 7] in population cells vs. 23.7 (17.3-28.7, n = 11) in JLN cells. In control cells, chronic moxifloxacin exposure (300 μM) mildly prolonged APD90 (10%) and increased IKs, while chronic exposure to dofetilide (5 nM) produced greater prolongation (67%) and no increase in IKs. However, in the siRNA-treated cells, moxifloxacin did not increase IKs and markedly prolonged APD90.

Conclusion: Our data strongly suggest that KCNQ1 expression modulates baseline cardiac repolarization, and the response to IKr block, through mechanisms beyond simply generating IKs.

References

Moskowitz I, Pizard A, Patel V, Bruneau B, Kim J, Kupershmidt S . The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development. 2004; 131(16):4107-16. DOI: 10.1242/dev.01265. View

Itoh H, Crotti L, Aiba T, Spazzolini C, Denjoy I, Fressart V . The genetics underlying acquired long QT syndrome: impact for genetic screening. Eur Heart J. 2015; 37(18):1456-64. PMC: 4914885. DOI: 10.1093/eurheartj/ehv695. View

Schwartz P, Spazzolini C, Crotti L, Bathen J, Amlie J, Timothy K . The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation. 2006; 113(6):783-90. DOI: 10.1161/CIRCULATIONAHA.105.592899. View

Kim E, Shekhar A, Lu J, Lin X, Liu F, Zhang J . PCP4 regulates Purkinje cell excitability and cardiac rhythmicity. J Clin Invest. 2014; 124(11):5027-36. PMC: 4321194. DOI: 10.1172/JCI77495. View

Nerbonne J, Kass R . Molecular physiology of cardiac repolarization. Physiol Rev. 2005; 85(4):1205-53. DOI: 10.1152/physrev.00002.2005. View

Qiu X, Chauveau S, Anyukhovsky E, Rahim T, Jiang Y, Harleton E . Increased Late Sodium Current Contributes to the Electrophysiological Effects of Chronic, but Not Acute, Dofetilide Administration. Circ Arrhythm Electrophysiol. 2016; 9(4):e003655. PMC: 4850912. DOI: 10.1161/CIRCEP.115.003655. View

Guo J, Wang T, Yang T, Xu J, Li W, Fridman M . Interaction between the cardiac rapidly (IKr) and slowly (IKs) activating delayed rectifier potassium channels revealed by low K+-induced hERG endocytic degradation. J Biol Chem. 2011; 286(40):34664-74. PMC: 3186392. DOI: 10.1074/jbc.M111.253351. View

Bersell K, Montgomery J, Kanagasundram A, Campbell C, Chung W, Macaya D . Partial Duplication and Poly(A) Insertion in KCNQ1 Not Detected by Next-Generation Sequencing in Jervell and Lange-Nielsen Syndrome. Circ Arrhythm Electrophysiol. 2016; 9(6). PMC: 4905601. DOI: 10.1161/CIRCEP.116.004081. View

Sanguinetti M, Jiang C, Curran M, Keating M . A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995; 81(2):299-307. DOI: 10.1016/0092-8674(95)90340-2. View

10.

Blinova K, Stohlman J, Vicente J, Chan D, Johannesen L, Hortigon-Vinagre M . Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias. Toxicol Sci. 2016; 155(1):234-247. PMC: 6093617. DOI: 10.1093/toxsci/kfw200. View

11.

Wu J, Sakaguchi T, Takenaka K, Toyoda F, Tsuji K, Matsuura H . A trafficking-deficient KCNQ1 mutation, T587M, causes a severe phenotype of long QT syndrome by interfering with intracellular hERG transport. J Cardiol. 2018; 73(5):343-350. DOI: 10.1016/j.jjcc.2018.10.011. View

12.

Brunner M, Peng X, Liu G, Ren X, Ziv O, Choi B . Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest. 2008; 118(6):2246-59. PMC: 2373420. DOI: 10.1172/JCI33578. View

13.

Franco D, Demolombe S, Kupershmidt S, Dumaine R, Dominguez J, Roden D . Divergent expression of delayed rectifier K(+) channel subunits during mouse heart development. Cardiovasc Res. 2001; 52(1):65-75. DOI: 10.1016/s0008-6363(01)00349-2. View

14.

Mitcheson J, Chen J, Lin M, Culberson C, Sanguinetti M . A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci U S A. 2000; 97(22):12329-33. PMC: 17341. DOI: 10.1073/pnas.210244497. View

15.

Zhang M, DAniello C, Verkerk A, Wrobel E, Frank S, Ward-van Oostwaard D . Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue. Proc Natl Acad Sci U S A. 2014; 111(50):E5383-92. PMC: 4273331. DOI: 10.1073/pnas.1419553111. View

16.

Jost N, Virag L, Bitay M, Takacs J, Lengyel C, Biliczki P . Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation. 2005; 112(10):1392-9. DOI: 10.1161/CIRCULATIONAHA.105.550111. View

17.

Sims C, Reisenweber S, Viswanathan P, Choi B, Walker W, Salama G . Sex, age, and regional differences in L-type calcium current are important determinants of arrhythmia phenotype in rabbit hearts with drug-induced long QT type 2. Circ Res. 2008; 102(9):e86-100. PMC: 2737508. DOI: 10.1161/CIRCRESAHA.108.173740. View

18.

Lahti A, Kujala V, Chapman H, Koivisto A, Pekkanen-Mattila M, Kerkela E . Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech. 2011; 5(2):220-30. PMC: 3291643. DOI: 10.1242/dmm.008409. View

19.

Moss A, Shimizu W, Wilde A, Towbin J, Zareba W, Robinson J . Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007; 115(19):2481-9. PMC: 3332528. DOI: 10.1161/CIRCULATIONAHA.106.665406. View

20.

Thompson E, Eldstrom J, Westhoff M, McAfee D, Balse E, Fedida D . cAMP-dependent regulation of single-channel kinetics. J Gen Physiol. 2017; 149(8):781-798. PMC: 5560775. DOI: 10.1085/jgp.201611734. View